Results 281 to 290 of about 305,984 (384)

Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models. [PDF]

EMBO Mol Med
Passadouro AS, Balfoort BM, Langeveld M, van Karnebeek CDM, van der Velden J, Houtkooper RH, Mosegaard S.   +6 more
europepmc   +1 more source

Endocardial Fibrotic Lesions Have a Greater Effect on Peak Longitudinal Strain than Epicardial Fibrotic Lesions in Hypertrophic Cardiomyopathy Patients

, 2018
Nobusada Funabashi, Hiroyuki Takaoka, Koya Ozawa, Yoshio Kobayashi   +3 more
openalex   +2 more sources

e0699 Late gadolinium-enhanced cardiac MRI in restrictive cardiomyopathy [PDF]

, 2010
Shihua Zhao, Shiliang Jiang, Huaibing Cheng, Lu Minjie, Li Jian, Yan Zhou, Chaowu Yan, Qiong Liu, Man Ning, L. Shiguo, Y. Gang   +10 more
openalex   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Use of pimobendan in cats: a practical evidence-based review. [PDF]

J Feline Med Surg
Gordon SG, Saunders AB, Wesselowski S, Malcolm EL, Watson A.   +4 more
europepmc   +1 more source

Idiopathic Cardiomyopathy

Japanese Journal of Medicine, 1977
openaire   +4 more sources

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Decoding Silent Signals: A Systematic Review of ECG and the Quest for an Early Diagnosis of Cirrhotic Cardiomyopathy. [PDF]

Cureus
Neelakantan Ramaswamy S, Harikrishnan S, Bhatt N, Agarwal Y, Chand S, Bendagiri Matam M, Mohammed L.   +6 more
europepmc   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

Leveraging artificial intelligence for risk stratification of inherited cardiomyopathies in under-resourced settings. [PDF]

Heart Rhythm O2
Alahwany SH, Kamel O, Abdelghany A, Ammar A.   +3 more
europepmc   +1 more source